"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Fabio Ynoe de Moraes: Key takeaways from the FDA’s first Digital Health Advisory Committee
Dual benefits of LXR activation in intestinal regeneration and CRC
10 Most Promising Cancer Drugs in 2024: What Patients Need to Know
Survival benefits of perioperative durvalumab with neoadjuvant chemotherapy in MIBC - ESMO
Jacob Adashek: Tissue is not the issue
Brenda Chahla: Honored to have presented our research on Pembrolizumab in ACC at the 9th International Adrenal Cancer Conference
